USAMMDA's Warfighter Protection and Acute Care Project Management Office, along with its commercial partner BioFire Defense, announced the FDA's 510 (k) clearance for BioFire's COVID-19 Test 2, which helps to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in approximately 45 minutes. (Photo courtesy of BioFire Defense)
| Date Taken: | 01.19.2022 |
| Date Posted: | 01.19.2022 11:19 |
| Photo ID: | 7015600 |
| VIRIN: | 220119-O-IE261-995 |
| Resolution: | 2150x1783 |
| Size: | 383.31 KB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 53 |
| Downloads: | 9 |
This work, USAMMDA Announces FDA 510 (k) Clearance of Rapid Diagnostic Test for COVID-19 [Image 2 of 2], by Jeffrey Soares, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
USAMMDA Announces FDA 510 (k) Clearance of Rapid Diagnostic Test for COVID-19
No keywords found.
